Featured posts

September 21, 2022

CTSW Represents Customer Research Technology Firm in Asset Purchase by Life Sciences Commercialization Company

CTSW represented a customer research technology firm in the sale of customer research technology to a life sciences commercialization company. The transaction is the latest in CTSW’s long history of work in M&A involving technology and life sciences. Robert Boghosian, Larry Tauber, and Monica Noguera worked on this transaction.

August 10, 2022

CTSW Represents Sellers of an International Business and Technology Consulting Firm

CTSW represented the sellers of an international business and enterprise technology consulting firm in a transaction with another large consulting firm. The transaction is the latest in CTSW’s M&A work with clients in technology services, solutions, and products. Larry Tauber, Russ Korins, and Monica Noguera worked on this transaction.

April 11, 2023

Daniel Arbov

Daniel Arbov is Counsel in CTSW’s Corporate Department. Admitted to practice in both New York and Israel, Daniel has a comprehensive background in M&A and tech, advising clients across a broad range of complex transactional matters. His practice spans early-stage and growth equity investments, mergers and acquisitions, joint ventures, and secondary transactions, representing EC/VC firms, […]

June 2, 2021

Irving L. Wiesen

Irving L. Wiesen, Esq. is a food and drug attorney with over thirty years experience in the industry. He specializes in food and drug law and other laws and regulations affecting the pharmaceutical, biotech and medical device industries. His practice includes counseling pharmaceutical and medical device companies in all areas of FDA compliance, drug marketing […]

June 1, 2021

Irving Fishman

Irving Fishman is both a registered patent attorney and licensed pharmacist with over twenty years’ experience in pharmaceutical and chemical patent issues. As U.S. Pharmaceutical Division Counsel for Ciba-Geigy Corp., Corporate Patent Counsel to Church & Dwight, and later in private practice, he prepared hundreds of validity/infringement opinions on generic, OTC and branded drugs and […]

Back

page